Karina Meijer
- Hematology top 0.2%
- Cardiology and Cardiovascular Medicine top 1%
- Internal Medicine top 0.2%
- Surgery top 5%
- Genetics top 2%
- Co-authors
- Frank W.G. LeebeekHanneke C. Kluin‐NelemansNic J.G.M. VeegerKarin FijnvandraatJeroen EikenboomJohanna G. van der BomMarjon H. CnossenRoger E. G. Schutgens
- Topics
- Hemophilia Treatment and Research (78 papers)Venous Thromboembolism Diagnosis and Management (71 papers)Platelet Disorders and Treatments (61 papers)
- Journals
- CirculationSHILAP Revista de lepidopterologíaBlood
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Karina Meijer
201 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 108
- Hematology 2.3k
- Cardiology and Cardiovascular Medicine 1.3k
- Internal Medicine 1.2k
- Surgery 612
- Genetics 482
Countries citing papers authored by Karina Meijer
This map shows the geographic impact of Karina Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karina Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karina Meijer more than expected).
Fields of papers citing papers by Karina Meijer
This network shows the impact of papers produced by Karina Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karina Meijer. The network helps show where Karina Meijer may publish in the future.
Co-authorship network of co-authors of Karina Meijer
This figure shows the co-authorship network connecting the top 25 collaborators of Karina Meijer. A scholar is included among the top collaborators of Karina Meijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karina Meijer. Karina Meijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 4 | |
| 8 | 9 | |
| 9 | 7 | |
| 10 | 7 | |
| 11 | 5 | |
| 12 | 15 | |
| 13 | 2 | |
| 14 | 18 | |
| 15 | 3 | |
| 16 | 5 | |
| 17 | 21 | |
| 18 | 2 | |
| 19 | [Von Willebrand disease in the Netherlands: the WiN study]. | 4 |
| 20 | Recombinant factor VIIa improves clot formation but not tafi-mediated downregulation of fibrinolysis in patients with cirrhosis and during liver transplantation. | 1 |
About Karina Meijer
Karina Meijer is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 220 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (78 papers), Venous Thromboembolism Diagnosis and Management (71 papers) and Platelet Disorders and Treatments (61 papers). The work is most often cited by research in Internal Medicine (1.2k citations), Hematology (2.3k citations) and Cardiology and Cardiovascular Medicine (1.3k citations). Karina Meijer has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Frank W.G. Leebeek, Hanneke C. Kluin‐Nelemans, Nic J.G.M. Veeger, Karin Fijnvandraat, Jeroen Eikenboom, Johanna G. van der Bom, Marjon H. Cnossen, Roger E. G. Schutgens, Nakisa Khorsand and Britta A. P. Laros‐van Gorkom. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.